Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
St Catherine's College In The University Of Oxford investment portfolio
St Catherine's College In The University Of Oxford has made numerous investments in companies such as Accession Therapeutics, Aistetic, and Etcembly within the Biotech sector.
university
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Accession Therapeutics Limited Accession Therapeutics Limited develops novel immuno‑oncology therapeutics using its Trocept platform, creating highly targeted treatments such as TROCEPT‑01, which is currently in a Phase 1 ATTEST trial for solid cancers. | BiotechHealth TechDeepTech | Oxford | Confirmed | 2025-12-14 |
| Aistetic Limited Aistetic Limited offers an AI‑driven software platform that automatically generates complete, marketplace‑ready product listings—including titles, descriptions, pricing and structured data—for fashion retailers and resale platforms, enabling them to list and sell items within the circular fashion market. | Software & IT | Abingdon | Confirmed | 2026-01-17 |
Shareholding changes (7)
St Catherine's College In The University Of Oxford's positions across portfolio companies2026
- A ORDINARY 97,570 → 146,355
2025
- A SHARES 0 → 4,532
Articles (1)
- Accession Therapeutics secures £5.7m to advance targeted cancer immunotherapies26 Mar 2026Accession Therapeutics